American College of Cardiology
Jun 11, 2026, 23:38
Why the New 2026 CKM Syndrome Guideline Changes Everything for Chronic Disease Prevention – American College of Cardiology
American College of Cardiology shared a post on LinkedIn:
“The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the ‘interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes), chronic kidney disease (CKD) and cardiovascular disease.’
The document retires, replaces and expands upon the 2013 Guideline for the Management of Overweight and Obesity in Adults.
Read the full guideline in JACC.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 16:39Asmaa M. Gouda: A Memorable Learning Experience in Immunohematology and Transfusion Medicine
-
Sep 13, 2026, 16:33Why the Immune Response Matters in Hemophilia Treatment – WFH
-
Sep 13, 2026, 16:29Alan Nurden։ How Platelets Amplify Thromboinflammation and NET Formation
-
Sep 13, 2026, 16:29Priya Prasad: How Frequent Blood Donors Can Prevent Hidden Iron Deficiency
-
Sep 13, 2026, 16:22Tiffany Hall: Why Standard Pre-Op Labs Miss High-Risk Patients?
-
Sep 13, 2026, 16:09Dimitrios Syrengelas: Haemophilia Care Begins With Safe Movement
-
Sep 13, 2026, 15:33Christina (Tina) P.: Antiphospholipid Syndrome After Unprovoked VTE
-
Sep 13, 2026, 15:22Ioana Alexandra Voda: The Story Gets More Time at IFOS Istanbul
-
Sep 13, 2026, 14:52Omar Al Hammadi: Integrating Diabetes and Dyslipidemia in Modern Clinical Care